European Pharmaceutical Review

DECEMBER 15, 2022

Lilly’s 30×30 initiative aims to improve access to quality healthcare for 30 million people living in limited-resource settings, annually, by 2030. Lilly will also provide a pro-bono technology transfer to enable EVA Pharma to formulate, fill and finish insulin vials and cartridges. . WHO’s Global Diabetes Compact.

Diabetes 74

Diabetes Packaging Communication 74

GMPSOP

MAY 26, 2023

Whatever the reason may be any change of raw material can directly impact product quality, manufacturing formulae, registration dossier, bill of materials, finished product shelf life, laboratory test method or specification, etc. – Estimation of resources required to bring about the change. – Specify urgency.

Documentation 52

Documentation Packaging Communication Customer Service 52

GMPSOP

MAY 26, 2023

Whatever the reason may be any change of raw material can directly impact product quality, manufacturing formulae, registration dossier, bill of materials, finished product shelf life, laboratory test method or specification, etc. – Estimation of resources required to bring about the change. – Specify urgency.

Documentation 52

Documentation Packaging Communication Customer Service 52

pharmaphorum

DECEMBER 13, 2021

The Covid-19 pandemic showed what could be done with resources and collaboration to accelerate the development of vaccines. It, too, announced plans to invest $500 million in a new facility in Africa for the production, fill/finish and packaging of mRNA vaccines.

Vaccines 105

Vaccines Packaging 105

Pharmaceutical Technology

DECEMBER 8, 2022

When we think of smart manufacturing in the biopharmaceutical industry, an automated manufacturing line for filling and finishing pharmaceutical vials might come to mind. Forward-thinking suppliers, including packaging component providers, are also looking at how they can improve their processes through digital technologies.

Packaging 98

Packaging Vaccines Communication Drug Development 98